Structure Therapeutics (GPCR) Current Leases (2022 - 2026)

Structure Therapeutics' Current Leases history runs 5 years deep, the most recent figure standing at $2.6 million for Q1 2026.

• On a quarterly basis, Current Leases rose 5.58% year-over-year to $2.6 million in Q1 2026; TTM through Mar 2026 was $2.6 million, a 5.58% increase from a year earlier, with the FY2025 full-year figure at $2.9 million, up 69.49% from the prior year.
• Current Leases declined to $2.6 million in Q1 2026 per GPCR's latest filing, from $2.9 million in the prior quarter.
• Across five years, Current Leases topped out at $2.9 million in Q4 2025 and bottomed at $73000.0 in Q2 2023.
• The 5-year median for Current Leases is $1.7 million (2024), against an average of $1.6 million.
• Across the five-year window, Current Leases jumped 2131.51% in 2024 and advanced 5.58% in 2026, its largest moves.
• Year by year, Current Leases stood at $260000.0 in 2022, then jumped by 453.85% to $1.4 million in 2023, then increased by 17.92% to $1.7 million in 2024, then jumped by 69.49% to $2.9 million in 2025, then declined by 9.35% to $2.6 million in 2026.
• Per Business Quant, the three latest GPCR Current Leases figures stand at $2.6 million (Q1 2026), $2.9 million (Q4 2025), and $2.8 million (Q3 2025).